This report analyses the annual private gross fixed capital formation attributable to research and development (R&D). This includes the sale price of purchased R&D and the value of R&D that is conducted in-house. The data for this report is sourced from the Australian Bureau of Statistics and is measured in billions of seasonally adjusted 2020-21 dollars.
IBISWorld expects private R&D expenditure to increase by 1.0% in 2024-25, to reach $19.7 billion. Interest rate hikes during 2022-23 substantially impacted borrowing costs, leading to a decline in business confidence and limiting investment in R&D. While the cash rate is anticipated steady in 2023-24, elevated interest rates are likely to continue hindering R&D expenditure growth. Nonetheless, the ongoing rebound from the pandemic-induced economic downturn is expected to support R&D expenditure growth in the current year, although to an increasinly lesser extent.
R&D is an important driver of economic growth in advanced economies. Developing economies are able to expand by increasing labour force participation, improving education and healthcare services and boosting labour efficiency by investing in capital equipment. Advanced economies tend to rely more on new technologies and R&D expenditure than developing economies, given that they are already much closer to full employment. In 1987-88, R&D spending in Australia accounted for 0.5% of GDP. This has increased over the past two decades, with R&D expenditure expected to account for 0.8% of GDP in 2024-25. Nevertheless, Australia’s share of GDP spent on R&D remains below the OECD average.
IBISWorld forecasts private expenditure on R&D to reach $20.3 b...